141 related articles for article (PubMed ID: 15217863)
1. WHO pulls two generic AIDS drugs from approved list.
Fleck F
BMJ; 2004 Jun; 328(7455):1518. PubMed ID: 15217863
[No Abstract] [Full Text] [Related]
2. Two AIDS medicines back on WHO prequalification list.
Wkly Epidemiol Rec; 2004 Dec; 79(50):449-50. PubMed ID: 15646322
[No Abstract] [Full Text] [Related]
3. AIDS treatment. A step toward cheaper anti-HIV therapy.
Cohen J
Science; 2005 Feb; 307(5710):653. PubMed ID: 15692020
[No Abstract] [Full Text] [Related]
4. GSK and Boehringer agree to generic AIDS drugs deal.
Nelson K
Lancet; 2003 Dec; 362(9401):2074. PubMed ID: 14700066
[No Abstract] [Full Text] [Related]
5. WHO pulls three more AIDS drugs from list.
Fleck F
BMJ; 2004 Aug; 329(7462):368. PubMed ID: 15310604
[No Abstract] [Full Text] [Related]
6. WHO removes 3 more AIDS drugs from approved list.
Bull World Health Organ; 2004 Sep; 82(9):718. PubMed ID: 15628217
[No Abstract] [Full Text] [Related]
7. New 20 year patents threaten to end AIDS drugs for developing countries.
Dyer O
BMJ; 2004 Dec; 329(7478):1308. PubMed ID: 15576738
[No Abstract] [Full Text] [Related]
8. Production of low cost AIDS drugs to continue in Brazil.
Reprod Health Matters; 2001 Nov; 9(18):178. PubMed ID: 11803899
[No Abstract] [Full Text] [Related]
9. [The patent legislation in India fails the HIV/AIDS work].
Holen Ø
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2666-7. PubMed ID: 16215618
[No Abstract] [Full Text] [Related]
10. FDA grants tentative approval for 75th generic antiretroviral drug.
Lang L
Gastroenterology; 2009 Jan; 136(1):5. PubMed ID: 19059409
[No Abstract] [Full Text] [Related]
11. WHO pulls Indian generics off AIDS drugs list.
Nat Med; 2004 Sep; 10(9):885. PubMed ID: 15340402
[No Abstract] [Full Text] [Related]
12. Several AIDS drugs tentatively approved.
FDA Consum; 2005; 39(5):3. PubMed ID: 16421982
[No Abstract] [Full Text] [Related]
13. WHO drops two generics from approved HIV drugs list.
Khan A
Lancet; 2004 Jun; 363(9427):2147. PubMed ID: 15222328
[No Abstract] [Full Text] [Related]
14. The AIDS response catalysing economic and social transformation: the importance of local pharmaceutical production.
Sidibé M
Antivir Ther; 2014; 19 Suppl 3():3-4. PubMed ID: 25310132
[No Abstract] [Full Text] [Related]
15. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
Cohen J
Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
[No Abstract] [Full Text] [Related]
16. International. Rights group: U.S. blocking access to generic AIDS drugs.
AIDS Policy Law; 2004 Apr; 19(7):1, 4. PubMed ID: 15124593
[No Abstract] [Full Text] [Related]
17. Low-cost generic drugs under the President's Emergency Plan for AIDS Relief drove down treatment cost; more are needed.
Venkatesh KK; Mayer KH; Carpenter CC
Health Aff (Millwood); 2012 Jul; 31(7):1429-38. PubMed ID: 22778332
[TBL] [Abstract][Full Text] [Related]
18. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
[No Abstract] [Full Text] [Related]
19. HIV/AIDS in China. A new treatment campaign, but with limited weapons.
Cohen J
Science; 2004 Jun; 304(5676):1433. PubMed ID: 15178778
[No Abstract] [Full Text] [Related]
20. AIDS treatment. Drugmakers test restrictions on generics in U.S. programs.
Cohen J
Science; 2004 Oct; 306(5694):213. PubMed ID: 15472049
[No Abstract] [Full Text] [Related]
[Next] [New Search]
